Specialize in land acquisition, land development, and real estate development, focusing on modern single family and multifamily homes.

License Number: 139800

• Led and supported all statistical aspects of multiple $1M+ clinical studies and collaborated with clinical project leaders, data managers, and CROs to ensure study objectives are achieved• Performed sample size and power calculations, SAP development and assisted with protocol development• Contributed to the preparation of FDA’s Tobacco Product Scientific Advisory Committee meeting (TPSAC) on Camel Snus Modified Risk Tobacco Product Application (MRTPA) by providing post-hoc analysis for 3 clinical studies and delivered results to the management team for them to develop presentation • Provided statistical support to FDA’s Advice/Information request on Premarket Tobacco Applications (PMTAs) and MRTPAs by re-analyzing reclassified subjects from a clinical study (320 subjects with 118 biomarkers) by tweaking programs left from a bankrupt CRO and recreated a complex analysis according to FDA’s request• Collaborated cross-functionally and provided internal consulting services to RAI subsidiary companies on multiple projects by conducting statistical analysis and drafting scientific report for internal use or publication

• Published: Masterson Creber, Ruth; Chen, Ting; Wei, Chao; Lee, Christopher S. Brief Report: Patient Activation Among Urban Hospitalized Patients With Heart Failure. Journal of Cardiac Failure, 11:817-820, August 2017• Created a structured database in SAS by combing data sources for validity of the study in a NIH-funded project• Utilized SQL to retrieve, edit and populate database tables and cleaned the dataset for efficient data analysis• Reported results of the statistical analysis in the form of graphs, charts and tables for principal investigator (PI) to review and to update team communication and collaboration

• Collaborated in giving parts of lectures to class for demonstrations• Participated in preparation for class materials of ‘Randomized Clinical Trials I’

• Analyzed microarray dataset using Bioconductor in R to identify differentially expressed genes (DEG) might be related to different smoking status in 200+ subjects• Assessed and visualized differentially expressed genes of smokers’ sub-groups using heatmap and used DAVID Bioinformatics to identify gene clusters and pathways of significantly DEG• Applied logistic regression to assess association between smoking exposure level and smokers’ demographic data and visualized data points between groups using GGplot • Drafted a scientific report and presented it to the Research and Development department director

• Participated in the literature review and study design of paramagnetic relaxation enhancement (PRE) experiment to exploit the sensitivity of nuclear spins to the presence of paramagnetic compounds• Collaborated with team members to present the research finding effectively to other researchers• Conducted RNA related experiments, recorded and managed experiment data